Opendata, web and dolomites

DIABETESMART

The first Clinically Validated AI-powered Diabetes Assistant

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 DIABETESMART project word cloud

Explore the words cloud of the DIABETESMART project. It provides you a very rough idea of what is the project "DIABETESMART" about.

clinical    2017    137    shown    18m    66    provides    2045    wearable    easier    danish    sugar    mobile    pioneer    patient    normal    stat    mission    2040    prevalence    start    phone    19    cagr    children    disease    powered    class    europes    least    blood    10b    642    daily    mellitus    benefit    75    integrate    device    people    forecast    28b    team    fatal    200    self    app    12    improvement    live    founded    artificial    mdr    glucose    million    individuals    diagnosed    care    platform    recommendations    foresee    diabetes    2021    revenues    hedia    cumulative    health    2026    insights    clinically    globally    intelligent    81    2016    corporates    diabetesmart    outperforms    validated    profits    26    potentially    lifestyle    2022    time    employees    2015    estimate    obtain    thousand    69    28       market    company    iia    ai    country    context    complications    chronic    415    25    medical    life    compliant    11    bellow    physician   

Project "DIABETESMART" data sheet

The following table provides information about the project.

Coordinator
HEDIA IVS 

Organization address
address: OLE MAALOES VEJ 3
city: KOBENHAVN
postcode: 2200
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2019-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    HEDIA IVS DK (KOBENHAVN) coordinator 50˙000.00

Map

 Project objective

Diabetes mellitus, a common chronic disease that is associated with high blood glucose (also called blood sugar) can lead to potentially fatal health complications. Globally, 415 million people were diagnosed with diabetes in 2015, estimated to reach 642 million by 2040. In Europe disease prevalence is high, 66 million people were diagnosed in 2017, estimate to reach 81 million people by 2045, with 28,200 children (bellow 19 years old) diagnosed each year. Diabetes requires long-life care management from a physician care team and patient daily self-management. Improvement of diabetes self-care was shown when people with diabetes used mobile phone application. Yet, the challenge is to identify a clinical relevant App between the thousand diabetes management applications available in the market. Hedia, a Danish pioneer start-up company was founded with the mission to make life easier for people with diabetes. Based on the current challenges, we have developed a mobile platform for the daily diabetes management that outperforms the current stat-of-the-art: clinically validated Class IIA compliant to Europes’s new MDR; an artificial intelligent powered that provides tailored recommendations based on the individuals lifestyle and country context; integrate the user’s blood medical device and wearable of choice and other advanced features that enable people with diabetes live a normal life. DIABETESMART project targets the diabetes care market, which has an estimate value of €69.10B in 2016, forecast to reach €137.28B by 2022 with a 12.4% CAGR (2016-2022). We aim to offer DIABETESMART to corporates -who will obtain further revenues of €18M per year- and to people with diabetes who will benefit from real-time clinically meaningful insights based on AI by 2021. We foresee to reach revenues of €26.6 million with €75.1 million in cumulative profits and increase our team to at least 25 employees (from current 11) by 2026.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DIABETESMART" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DIABETESMART" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

In-Heal (2019)

Standardised administration device for raw medical herbs

Read More  

MCBD (2019)

MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE

Read More  

RoboSynFarm (2019)

Robotic Synthesis Farm

Read More